New Four-Pronged weapon tested against tough blood cancers

NCT ID NCT04606433

Summary

This is an early-stage study testing the safety and dosing of a new experimental drug called GNC-038 in adults with aggressive blood cancers that have returned or not responded to standard treatments. The drug is a 'quad-specific antibody' designed to attack cancer cells by binding to four different targets at once. The main goals are to find the safest dose and see how the body handles the drug, while also checking for any early signs that it might help control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chongqing University Cancer Hospital

    Chongqing, Chongqing Municipality, China

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China

  • Hematology Hospital, Chinese Academy of Medical Sciences

    Tianjin, Tianjin Municipality, 300000, China

  • Nanfang Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China

  • Shanghai Tongji Hospital

    Shanghai, Shanghai Municipality, China

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • The Second Hospital of Anhui Medical University

    Hefei, Anhui, China

  • Xiangya Hospital Central South University

    Changsha, Hunan, China

Conditions

Explore the condition pages connected to this study.